MoneyWorks4Me

The sales surged to Rs. 3041.61 millions, up 38.29% for the March 2025 quarter as against Rs. 2199.38 millions during the corresponding quarter previous year.Profit for the quarter ended March 2025 rises by 95.91% to Rs. 628.48  millions from Rs. 320.80 millions.Operating Profit saw a handsome growth to 897.52 millions from 487.07 millions in the quarter ended March 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 3041.61 2199.38 38.29 9898.35 6875.83 43.96 9898.35 6875.83 43.96
Other Income 56.94 85.54 -33.43 183.36 137.86 33.00 183.36 137.86 33.00
PBIDT 897.52 487.07 84.27 2434.78 1214.53 100.47 2434.78 1214.53 100.47
Interest 3.83 20.56 -81.37 58.57 58.94 -0.63 58.57 58.94 -0.63
PBDT 893.69 466.51 91.57 2376.21 838.05 183.54 2376.21 838.05 183.54
Depreciation 65.56 43.63 50.26 240.45 146.94 63.64 240.45 146.94 63.64
PBT 828.13 422.88 95.83 2135.76 691.11 209.03 2135.76 691.11 209.03
TAX 199.65 102.08 95.58 540.29 254.25 112.50 540.29 254.25 112.50
Deferred Tax 47.36 29.02 63.20 70.58 45.12 56.43 70.58 45.12 56.43
PAT 628.48 320.80 95.91 1595.47 436.86 265.21 1595.47 436.86 265.21
Equity 409.34 368.81 10.99 409.34 368.81 10.99 409.34 368.81 10.99
PBIDTM(%) 29.51 22.15 33.24 24.60 17.66 39.26 24.60 17.66 39.26
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..